Oncimmune Holdings plc (LON: ONC), a leader in the development, manufacture and commercialisation of personalised immunodiagnostics for the screening, detection and care of cancer, today announced its distributor in Columbia, Valentech International LLC, has obtained regulatory approval for the sale of EarlyCDT-Lung.
Oncimmune has an existing signed distribution agreement with Valentech for Brazil and Columbia. Columbia has a population of 49.7 million and an estimated 12 in every 100,000 of the population die of lung cancer every year.